{"SPADE_UN_26932": {"basic": {"SPADE ID": "SPADE_UN_26932", "Peptide Name": "LP1 [K1,2,3,4,27,30H;Q28H;N29H]/LP40", "Sequence": "HHHHLKKILKKLFQFINQLDNQLQDIHHHH", "Source": "", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Target Organism": "Escherichia coli TOP 10(MIC=>50µM),Staphylococcus carnosus CCM 4838T(MIC=>50µM),Enterococcus faecalis ATCC 700802(MIC=>60µM),Enterococcus faecium ATCC 700221(MIC=>60µM),Staphylococcus aureus ATCC 12600(MIC=>60µM),Staphylococcus aureus ATCC BAA-1556(MIC=>60µM),Klebsiella pneumoniae ATCC 13883(MIC=0.6µM),Acinetobacter baumannii ATCC 19606(MIC=8µM),Pseudomonas aeruginosa PAO1(MIC=>60µM),Pseudomonas aeruginosa PA14(MIC=>60µM),Escherichia coli ATCC 11775(MIC=8µM),Escherichia coli AIC221(MIC=12µM),Escherichia coli AIC222(MIC=12µM),Human renal carcinoma A498(IC50=20µM),Human lung carcinoma A549(IC50=97µM),Human kidney carcinoma Caki-1(IC50=23µM),Human prostate cancer DU145(IC50=60µM),Human lung carcinoma NCI-H460(IC50=>200µM),Human colon adenocarcinoma HCT 116(IC50=79µM),Human colon adenocarcinoma HCT-15(IC50=7.1µM),Human promyelocytic leukemia HL-60(IC50=7.2µM),Human myelogenous leukemia K562(IC50=6.4µM),Human breast adenocarcinoma MCF-7(IC50=70µM),Human breast adenocarcinoma MDA-MB-231(IC50=61µM),Human breast adenocarcinoma MDA-MB-435(IC50=190µM),Human lymphoblastic leukemia Molt-4(IC50=>200µM),Human epithelial carcinoma OVCAR-3(IC50=9µM),Human prostate adenocarcinoma PC-3(IC50=91µM),Human Myeloma cells RPMI-8226(IC50=5.6µM),Human ovarian adenocarcinoma SK-OV-3(IC50=110µM),Human colon adenocarcinoma SW620(IC50=140µM),Human breast cancer T47D(IC50=4.6µM),Human glioblastoma U251-MG(IC50=>200µM)", "Sequence Length": 30}, "extended_data_url": "SPADE_UN_26932_extended.json"}}